SCIENTURE HOLDINGS, INC. Disposal Group, Including Discontinued Operation, Operating Expense
SCIENTURE HOLDINGS, INC. (SCNX) reported Disposal Group, Including Discontinued Operation, Operating Expense of $902.72 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, operating expense for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, operating expense for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, operating expense for the quarter ending 2024-06-30 was $209.16K, a 84.20% decline year-over-year.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, operating expense for the quarter ending 2024-03-31 was $693.56K, a 32.35% decline year-over-year.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, operating expense for fiscal 2024 was $902.72K, a 85.04% decline from fiscal 2023.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, operating expense for fiscal 2023 was $6.03M, a 318.90% increase from fiscal 2022.
- SCIENTURE HOLDINGS, INC. disposal group, including discontinued operation, operating expense for fiscal 2022 was $1.44M.
| Period end | Disposal Group, Including Discontinued Operation, Operating Expense 3 month | Disposal Group, Including Discontinued Operation, Operating Expense 3 month as first filed | Disposal Group, Including Discontinued Operation, Operating Expense 6 month | Disposal Group, Including Discontinued Operation, Operating Expense 9 month | Disposal Group, Including Discontinued Operation, Operating Expense 9 month as first filed | Disposal Group, Including Discontinued Operation, Operating Expense 12 month | Disposal Group, Including Discontinued Operation, Operating Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $209.16K derived: sum of 3 quarters · filed 2026-03-30 | $902.72K 10-K · filed 2026-03-30 | $902.72K 10-K · filed 2025-03-26 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $209.16K derived: sum of 2 quarters · filed 2025-11-12 | $902.72K 10-Q · filed 2025-11-12 | $902.72K 10-Q · filed 2024-11-06 | $2.66M derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $209.16K 10-Q · filed 2025-08-12 | $902.72K 10-Q · filed 2025-08-12 | $2.66M derived: sum of 3 quarters · filed 2025-08-12 | $4.55M derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | $693.56K 10-Q · filed 2025-05-12 | $690.06K 10-Q · filed 2024-06-26 | $2.45M derived: sum of 2 quarters · filed 2025-05-12 | $4.34M derived: sum of 3 quarters · filed 2025-05-12 | $5.66M derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $3.64M derived: sum of 2 quarters · filed 2025-03-26 | $4.97M derived: sum of 3 quarters · filed 2025-03-26 | $6.03M 10-K · filed 2025-03-26 | $617.11K 10-K · filed 2024-04-22 | ||
| 2023-09-30 | $1.89M 10-Q · filed 2024-11-06 | $140.30K 10-Q · filed 2024-01-16 | $3.21M derived: sum of 2 quarters · filed 2024-11-06 | $4.28M 10-Q · filed 2024-11-06 | $617.11K 10-Q · filed 2024-01-16 | $5.15M derived: sum of 4 quarters · filed 2024-11-06 | |
| 2023-06-30 | $1.32M 10-Q · filed 2024-08-09 | $2.39M 10-Q · filed 2024-08-09 | $3.26M derived: sum of 3 quarters · filed 2024-08-09 | $3.48M derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | $1.03M 10-Q · filed 2024-06-26 | $1.93M derived: sum of 2 quarters · filed 2024-06-26 | $2.15M derived: sum of 3 quarters · filed 2024-06-26 | ||||
| 2022-12-31 | $909.24K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | $1.13M derived: sum of 2 quarters · filed 2024-04-22 | $1.44M 10-K · filed 2024-04-22 | ||||
| 2022-09-30 | $219.73K 10-Q · filed 2024-01-16 | $531.03K 10-Q · filed 2024-01-16 | |||||
| 2016-09-30 | $508.45K 10-Q · filed 2017-11-07 | $1.01M derived: sum of 2 quarters · filed 2017-11-07 | $1.39M 10-Q · filed 2017-11-07 | ||||
| 2016-06-30 | $497.19K 10-Q · filed 2017-08-04 | $878.81K 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |